S. AUREUS ALLERGEN

The invention discloses the use of a protein with an amino acid sequence according to SEQ. ID. NO.l or a naturally occurring fragment or variant thereof for identifying infections with S. aureus in a human sample. More specifically, IgE molecules specific for SEQ. ID. NO.l are detected in the sample...

Full description

Saved in:
Bibliographic Details
Main Authors LINHART, BIRGIT, THALHAMER, JOSEF, VALENTA, RUDOLF, GREISENEGGER, ELLI, REGINALD, KAVITA, STOECKLINGER, ANGELIKA, HIRSCHL, ALEXANDER, M, WERFEL, THOMAS, KOPP, TAMARA, WESTRITSCHING, KERSTIN
Format Patent
LanguageEnglish
French
Published 17.03.2011
Subjects
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

More Information
Summary:The invention discloses the use of a protein with an amino acid sequence according to SEQ. ID. NO.l or a naturally occurring fragment or variant thereof for identifying infections with S. aureus in a human sample. More specifically, IgE molecules specific for SEQ. ID. NO.l are detected in the sample of the patient. Many atopic dermatitis patients have IgE specific for SEQ. ID. NO.1. L'invention concerne l'utilisation d'une protéine avec une séquence d'acides aminés selon SEQ. ID. NO.l ou un fragment d'origine naturelle ou un variant de celui-ci pour identifier des infections par S. aureus dans un échantillon humain. Plus spécifiquement, des molécules d'IgE spécifiques de SEQ. ID. NO.l sont détectées dans l'échantillon du patient. De nombreux patients atteints de dermatite atopique ont des IgE spécifiques pour SEQ. ID. NO.l.
Bibliography:Application Number: WO2010EP05561